October 24, 2016 / 11:32 PM / a year ago

BRIEF-Theratechnologies announces end of patient treatment for late-stage ibalizumab trial

Oct 24 (Reuters) - Theratechnologies Inc

* Announces end of patient treatment for phase III ibalizumab trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below